The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
from NPR Topics: News https://ift.tt/lF4GLQk
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Comments
Post a Comment